Bridgewater Associates’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Buy
1,152,000
+1,067,947
+1,271% +$11.9M 0.04% 326
2026
Q1
$910K Sell
84,053
-180,210
-68% -$1.54M ﹤0.01% 802
2025
Q4
$1.61M Buy
264,263
+243,110
+1,149% +$1.45M 0.01% 811
2025
Q3
$110K Buy
+21,153
New +$122K ﹤0.01% 1013
2024
Q3
Sell
-775,256
Closed -$8.03M 897
2024
Q2
$8.03M Buy
775,256
+312,529
+68% +$3.43M 0.04% 283
2024
Q1
$5.52M Buy
+462,727
New +$5.14M 0.03% 364
2023
Q4
Sell
-533,227
Closed -$7.38M 798
2023
Q3
$7.38M Buy
533,227
+373,597
+234% +$5.47M 0.04% 285
2023
Q2
$1.91M Buy
+159,630
New +$1.8M 0.01% 467
2014
Q3
Sell
-37,444
Closed -$1.31M 416
2014
Q2
$1.31M Sell
37,444
-63,138
-63% -$2.07M 0.01% 218
2014
Q1
$3.19M Sell
100,582
-37,700
-27% -$1.05M 0.03% 151
2013
Q4
$3.5M Buy
138,282
+67,100
+94% +$1.61M 0.03% 142
2013
Q3
$1.52M Sell
71,182
-59,332
-45% -$1.22M 0.01% 180
2013
Q2
$2.53M Buy
+130,514
New +$2.85M 0.02% 142

Other funds holding PTEN

Bridgewater Associates's PTEN Position: Q2 2026 in Review

Bridgewater Associates increased its Patterson-UTI (PTEN) stake by 1,271% in Q2 2026, buying an estimated $11.9M and bringing the position to 1,152,000 shares worth $10.6M. The position accounts for 0.04% of the portfolio, ranked #326.

Bridgewater Associates first reported a position in PTEN in Q2 2013 and has held it in 13 quarters since. 437 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Bridgewater Associates held 1,152,000 shares of Patterson-UTI worth $10.6M as of Q2 2026.
  • Bridgewater Associates bought 1,067,947 Patterson-UTI shares in Q2 2026, an estimated $11.9M.
  • Patterson-UTI made up 0.04% of Bridgewater Associates's portfolio in Q2 2026, its #326 holding.
  • Bridgewater Associates first reported a position in Patterson-UTI in Q2 2013 and has held it in 13 quarters since.
  • 437 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.